Covalent binding of carbamazepine reactive metabolites to P450 isoforms present in the skin

被引:56
作者
Wolkenstein, P [1 ]
Tan, C
Lecoeur, S
Wechsler, J
Garcia-Martin, N
Charue, D
Bagot, M
Beaune, P
机构
[1] Univ Paris 12, CHU Henri Mondor, Dept Dermatol, F-94010 Creteil, France
[2] CHU Necker Enfants Malad, INSERM, U75, F-75730 Paris, France
[3] Univ Paris 12, CHU Henri Mondor, Dept Pathol, F-94010 Creteil, France
关键词
carbamazepine; cytochrome P450 3A4; cytochrome P450 1A2; reactive metabolites; skin; hypersensitivity;
D O I
10.1016/S0009-2797(98)00021-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Carbamazepine is an anticonvulsant associated with a high risk for severe cutaneous reactions. Upon metabolism by cytochrome P450, carbamazepine may produce reactive metabolites. We evaluated in vitro the covalent binding of carbamazepine reactive metabolites on human P450s and then the presence of these P450s in human epidermis. Carbamazepine reactive metabolites covalent binding to human liver microsomes involved P450 subfamilies 1A, 2C and 3A. Specific covalent binding to yeasts expressing different P450s showed that carbamazepine reactive metabolites bound specifically to P450 1A2 and 3A4. We confirmed the constitutive presence of P450 3A in human epidermis and after induction with coaltar of P450 IA. Consequently, the production in epidermis of carbamazepine reactive metabolites is theoretically possible with formation of P450 adduct metabolites. (C) 1998 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:39 / 50
页数:12
相关论文
共 30 条
[1]   MONOCLONAL-ANTIBODIES AGAINST HUMAN-LIVER CYTOCHROME-P-450 [J].
BEAUNE, P ;
KREMERS, P ;
LETAWEGOUJON, F ;
GIELEN, JE .
BIOCHEMICAL PHARMACOLOGY, 1985, 34 (19) :3547-3552
[2]  
BOURDI M, 1992, MOL PHARMACOL, V42, P280
[3]   HYDROXYLATION AND FORMATION OF ELECTROPHILIC METABOLITES OF TIENILIC ACID AND ITS ISOMER BY HUMAN LIVER-MICROSOMES - CATALYSIS BY A CYTOCHROME-P450 IIC DIFFERENT FROM THAT RESPONSIBLE FOR MEPHENYTOIN HYDROXYLATION [J].
DANSETTE, PM ;
AMAR, C ;
VALADON, P ;
PONS, C ;
BEAUNE, PH ;
MANSUY, D .
BIOCHEMICAL PHARMACOLOGY, 1991, 41 (04) :553-560
[4]  
GOLDSTEIN JA, 1992, J BASIC CLIN PHYSL S, V3, P128
[5]  
GUENGERICH FP, 1991, J PHARMACOL EXP THER, V256, P1189
[6]  
Hirel B, 1996, BRIT J DERMATOL, V134, P831
[7]   IN-VITRO EXPRESSION OF DRUG-METABOLIZING ENZYME-ACTIVITIES IN HUMAN ADULT KERATINOCYTES UNDER VARIOUS CULTURE CONDITIONS AND THEIR RESPONSE TO INDUCERS [J].
HIREL, B ;
CHESNE, C ;
PAILHERET, JP ;
GUILLOUZO, A .
TOXICOLOGY IN VITRO, 1995, 9 (01) :49-56
[8]   MULTIPLE CYTOCHROME-P450 ISOZYMES IN MURINE SKIN - INDUCTION OF P450 1A, 2B, 2E, AND 3A BY DEXAMETHASONE [J].
JUGERT, FK ;
AGARWAL, R ;
KUHN, A ;
BICKERS, DR ;
MERK, HF ;
MUKHTAR, H .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1994, 102 (06) :970-975
[9]   HUMAN LIVER CARBAMAZEPINE METABOLISM - ROLE OF CYP3A4 AND CYP2C8 IN 10,11-EPOXIDE FORMATION [J].
KERR, BM ;
THUMMEL, KE ;
WURDEN, CJ ;
KLEIN, SM ;
KROETZ, DL ;
GONZALEZ, FJ ;
LEVY, RH .
BIOCHEMICAL PHARMACOLOGY, 1994, 47 (11) :1969-1979
[10]   MONOCLONAL-ANTIBODIES DIRECTED CHARACTERIZATION OF EPIDERMAL AND HEPATIC CYTOCHROME-P-450 ISOZYMES INDUCED BY SKIN APPLICATION OF THERAPEUTIC CRUDE COAL-TAR [J].
KHAN, WA ;
PARK, SS ;
GELBOIN, HV ;
BICKERS, DR ;
MUKHTAR, H .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1989, 93 (01) :40-45